IL11 and neoplasm: We validated, for the first time, IL-11 gene and protein expression in situ by performing RT-qPCR and immunohistochemistry on paired tumor and adjacent normal lung biopsies in NSCLC patients recruited through the National Heart Center Singapore, demonstrating a tumor-centric upregulation of IL-11 in NSCLC.